Peer-Reviewed Research Is Redefining Weight Loss Program Standards
Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation
Why Medifast's $15 Cash Per Share Makes It A Strong Buy
Medifast: Worth Putting On A Watchlist
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
Medifast, Inc. (MED) Q1 2026 Earnings Call Transcript
Medifast (MED) Reports Q1 Loss, Tops Revenue Estimates
Medifast Announces First Quarter 2026 Financial Results
Medifast's Q1 Earnings on The Horizon: Key Insights for Investors
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Medifast, Inc. (NYSE: MED)
Medifast's New Product Pipeline: Key Catalyst for Comeback?
Medifast (NYSE:MED) CEO Acquires $178,724.58 in Stock
Medifast Announces Cooperation Agreement with Steamboat Capital
Medifast (MED) Down 5.7% Since Last Earnings Report: Can It Rebound?
Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
Medifast Q4 Earnings Call Highlights
Medifast Q4 Loss Wider Than Expected, Revenues Decline 37% Y/Y
Medifast (MED) Reports Q4 Loss, Beats Revenue Estimates
Medifast, Inc. (MED) Q4 2025 Earnings Call Transcript
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
Medifast's Q4 Earnings on Deck: What Could Shape MED's Results?
Analysts Estimate Medifast (MED) to Report a Decline in Earnings: What to Look Out for
Medifast (MED) to Release Earnings on Tuesday
Medifast Is A Net-Net With Negative Enterprise Value
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025
Medifast's Q4 Guidance Remains Weak: When Does Growth Return?
The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings
People Magazine Spotlights Tiffany Howard's Metabolic Health Journey with OPTAVIA®
OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity
Medifast Shifts to Metabolic Health: A Durable Growth Path?
Medifast Announces Planned Leadership Transition
Medifast New Product Line Planned: Can Innovation Reignite Demand?
Medifast's Third-Quarter Revenue Fell 36%: Is Stabilization Near?
Can Medifast Overcome GLP-1 Pressure With Its Growth Strategy?
Vital Farms (NASDAQ:VITL) versus Medifast (NYSE:MED) Critical Comparison
OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
Medifast (NYSE:MED) and BAB (OTCMKTS:BABB) Financial Survey
Critical Comparison: Celsius (NASDAQ:CELH) versus Medifast (NYSE:MED)
Marzetti (NASDAQ:MZTI) vs. Medifast (NYSE:MED) Financial Comparison
Acadian Asset Management LLC Grows Stock Position in Medifast Inc $MED
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
Medifast (NYSE:MED) and Celsius (NASDAQ:CELH) Head to Head Review
Medifast's Q3 Loss Wider Than Expected, Sales Decline 36% Y/Y
Medifast, Inc. (MED) Q3 2025 Earnings Call Transcript
Medifast Announces Third Quarter 2025 Financial Results
Cwm LLC Purchases 6,335 Shares of Medifast Inc $MED
Medifast (MED) Expected to Release Earnings on Monday
Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025